FDA approval letter for daclizumab for the prophylaxis of acute organ rejection in patients receiving renal transplants
Food and Drug Administration, 10 Dec 1997
Accessed on 3 Dec 2011 from http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm113466.pdf.
